SubscribeLogin
Published

Biden proposes Medicare and Medicaid cover costly weight-loss drugs for millions of obese Americans

  • The Biden administration announced new plans to provide Medicare and Medicaid coverage for anti-obesity medications like Wegovy and Zepbound.
  • An estimated 3.5 million people on Medicare and 4 million on Medicaid could qualify for coverage under the proposal.
  • The rule would recognize obesity as a disease and may create a taxpayer cost of up to $35 billion over the next decade.
Insights by Ground AI
Does this summary seem wrong?
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center
49% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

Joe BidenJoe Biden
DiabetesDiabetes
WegovyWegovy
ObesityObesity
Democratic PartyDemocratic Party
HospitalsHospitals
PoliticsPolitics
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal